Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA

Anand Srivastava (1) , Stéphane Gangnard (2) , Adam Round (3) , Sébastien Dechavanne (1) , Alexandre Juillerat (2) , Bertrand Raynal (4) , Grazyna Faure (2) , Bruno Baron (4) , Stéphanie Ramboarina (2) , Saurabh K Singh (3) , Hassan Belrhali (3) , Patrick England (4) , Anita Lewit-Bentley (2) , Artur Scherf (1) , Graham A Bentley (2) , Benoît Gamain (1)

1 Biologie des Interactions Hôte-Parasite
2 Immunologie structurale
3 EMBL - European Molecular Biology Laboratory [Grenoble]
4 Biophysique des Macromolécules et de leurs Interactions

Pregnancy-associated malaria (PAM) is a serious consequence of sequestration of Plasmodium falciparum-parasitized erythrocytes (PE) in the placenta through adhesion to chondroitin sulfate A (CSA) present on placental proteoglycans. Recent work implicates var2CSA, a member of the PfEMP1 family, as the mediator of placental sequestration and as a key target for PAM vaccine development. Var2CSA is a 350 kDa transmembrane protein, whose extracellular region includes six Duffy-binding-like (DBL) domains. Due to its size and high cysteine content, the full-length var2CSA extracellular region has not hitherto been expressed in heterologous systems, thus limiting investigations to individual recombinant domains. Here we report for the first time the expression of the full-length var2CSA extracellular region (domains DBL1X to DBL6epsilon) from the 3D7 parasite strain using the human embryonic kidney 293 cell line. We show that the recombinant extracellular var2CSA region is correctly folded and that, unlike the individual DBL domains, it binds with high affinity and specificity to CSA (K(D) = 61 nM) and efficiently inhibits PE from binding to CSA. Structural characterization by analytical ultracentrifugation and small-angle x-ray scattering reveals a compact organization of the full-length protein, most likely governed by specific interdomain interactions, rather than an extended structure. Collectively, these data suggest that a high-affinity, CSA-specific binding site is formed by the higher-order structure of the var2CSA extracellular region. These results have important consequences for the development of an effective vaccine and therapeutic inhibitors.

Domaines: Sciences du Vivant [q-bio]

Anand Srivastava, Stéphane Gangnard, Adam Round, Sébastien Dechavanne, Alexandre Juillerat, et al.. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proceedings of the National Academy of Sciences of the United States of America, 2009, 107 (11), pp.4884 - 4889. ⟨10.1073/pnas.1000951107⟩. ⟨pasteur-03525650⟩